Identification of multiple Epstein-Barr virus-induced nuclear antigens with sera from patients with rheumatoid arthritis

No abstract is available for this paper.

• Publication year

  1984

• Venue

  Journal of Virology

• Publication date

  1984-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1128/jvi.52.1.88-93.1984PMID 6090712PMCID PMC254493
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• One of two Epstein-Barr virus nuclear antigens contains a glycine-alanine copolymer domain.

  1983cited by this paper
• A comparison of Epstein-Barr virus-specific T-cell immunity in rheumatoid arthritis and osteoarthritis patients.

  1983cited by this paper
• Partial purification of the Epstein-Barr virus nuclear antigen(s).

  1983cited by this paper
• Two Epstein-Barr viral nuclear neoantigens distinguished by gene transfer, serology, and chromosome binding.

  1983cited by this paper
• Evidence for two classes of chromatin-associated Epstein-Barr virus-determined nuclear antigen

  1982cited by this paper
• "Western blotting": electrophoretic transfer of proteins from sodium dodecyl sulfate--polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A.

  1981cited by this paper
• Identification of an Epstein-Barr virus nuclear antigen by fluoroimmunoelectrophoresis and radioimmunoelectrophoresis

  1981cited by this paper
• Characteristics of antinuclear antibodies in rheumatoid arthritis. Reactivity of rheumatoid factor with a histone-dependent nuclear antigen.

  1980cited by this paper
• Blocking of acid-fixed nuclear binding of Epstein-Barr virus nuclear antigen (EBNA) by different DNA species.

  1979cited by this paper
• Epstein-Barr Virus-Specific RNA III. Mapping of DNA Encoding Viral RNA in Restringent Infection

  1979cited by this paper
• Inducibility of the Epstein‐Barr virus (EBV) cycle and surface marker properties of ebv‐negative lymphoma lines and their in vitro EBV‐converted sublines

  1976cited by this paper
• Establishment of EBNA‐expressing cell lines by infection of Epstein‐Barr virus (EBV)‐genome‐negative human lymphoma cells with different EBV strains

  1976cited by this paper
• An EBV-genome-negative cell line established from an American Burkitt lymphoma; receptor characteristics. EBV infectibility and permanent conversion into EBV-positive sublines by in vitro infection.

  1975cited by this paper
• Continuous lymphoid cell lines with characteristics of B cells (bone-marrow-derived), lacking the Epstein-Barr virus genome and derived from three human lymphomas.

  1974cited by this paper
• COMPARISON OF THE YIELD OF INFECTIOUS VIRUS FROM CLONES OF HUMAN AND SIMIAN LYMPHOBLASTOID LINES TRANSFORMED BY EPSTEIN-BARR VIRUS

  1973cited by this paper
• Cellular localization of an Epstein‐Barr virus (EBV)‐associated complement‐fixing antigen in producer and non‐producer lymphoblastoid cell lines

  1973cited by this paper
• Relationship between the sensitivity of EBV‐carrying lymphoblastoid lines to superinfection and the inducibility of the resident viral genome

  1973cited by this paper
• Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

  1970cited by this paper
• Identification of the filtrable leukocyte‐transforming factor of qimr‐wil cells as herpes‐like virus

  1969cited by this paper
• Establishment of cell lines from Australian leukaemic patients: presence of a herpes-like virus.

  1968cited by this paper
• Burkitt lymphoma in New Guinea: establishment of a line of lymphoblasts in vitro and description of their fine structure.

  1967cited by this paper
• Immunofluorescence and Herpes-Type Virus Particles in the P3HR-1 Burkitt Lymphoma Cell Line

  1967cited by this paper
• Morphological and virological investigations on cultured Burkitt tumor lymphoblasts (strain Raji).

  1966cited by this paper
• Immunofluorescence in Cells Derived from Burkitt's Lymphoma

  1966cited by this paper

• Epstein-Barr virus is the cause of rheumatoid arthritis

  2018cites this paper
• Detection of Epstein-Barr virus in synovial fluid of rheumatoid arthritis patients

  2016cites this paper
• New Type B Isolates of Epstein-Barr Virus from Burkitt ' s Lymphoma and from Normal Individuals in Endemic Areas

  2007cites this paper
• Role of infectious agents in autoimmunity

  2007cites this paper
• Prediction of BRCA1 and BRCA2 mutation status using post-irradiation assays of lymphoblastoid cell lines is compromised by inter-cell-line phenotypic variability

  2007cites this paper
• Elevated immunoglobulin G antibodies to the proline‐rich amino‐terminal region of Epstein–Barr virus nuclear antigen‐2 in sera from patients with systemic connective tissue diseases and from a subgroup of Sjögren's syndrome patients with pulmonary involvements

  2005cites this paper
• Rheumatoid Factors Induce Signaling from B Cells, Leading to Epstein-Barr Virus and B-Cell Activation

  2004cites this paper
• Latent Epstein–Barr virus (EBV) infection and cytomegalovirus (CMV) infection in synovial tissue of autoimmune chronic arthritis determined by RNA- and DNA-in situ hybridization

  2004cites this paper
• The Epstein-Barr virus in autoimmunity

  2004cites this paper
• Replicative multivirus infection with cytomegalovirus, herpes simplex virus 1, and parvovirus B19, and latent Epstein-Barr virus infection in the synovial tissue of a psoriatic arthritis patient.

  2004cites this paper
• The EBNA- 3 gene family proteins disrupt the G2/M checkpoint

  2004cites this paper
• Leading article: Epstein-Barr virus infection and autoimmunity in rheumatoid arthritis

  2004cites this paper
• Detection of Parvovirus B19 Capsid Proteins in Lymphocytic Cells in Synovial Tissue of Autoimmune Chronic Arthritis

  2003cites this paper
• Infectious agents in arthritis and autoimmunity

  2003cites this paper
• A histone deacetylase inhibitor, azelaic bishydroxamic acid, shows cytotoxicity on Epstein-Barr virus transformed B-cell lines: a potential therapy for posttransplant lymphoproliferative disease.

  2002cites this paper
• Immune Responses to Epstein-Barr Viral Infection

  2002cites this paper
• Molecular virology of Epstein-Barr virus.

  2001cites this paper
• Differential Immunogenicity of Epstein-Barr Virus Latent-Cycle Proteins for Human CD4+ T-Helper 1 Responses

  2001cites this paper
• Lytic Epstein-Barr virus infection in the synovial tissue of patients with rheumatoid arthritis.

  2000cites this paper
• Characterization of the transcriptional repressor RBP in Epstein-Barr virus-transformed B cells.

  1999cites this paper
• Epstein-Barr virus immortalization and latency.

  1999cites this paper
• Regulation of interleukin-1beta transcription by Epstein-Barr virus involves a number of latent proteins via their interaction with RBP.

  1998cites this paper
• Detection of Epstein-Barr virus and cytomegalovirus genome in white blood cells from patients with juvenile rheumatoid arthritis and childhood systemic lupus erythematosus.

  1995cites this paper
• Two malignant peripheral primitive neuroepithelial tumor cell lines established from consecutive samples of one patient: Characterization and cytogenetic analysis

  1992cites this paper
• Analysis of antibody titers to Epstein-Barr virus nuclear antigens in sera of patients with Sjögren's syndrome and with rheumatoid arthritis.

  1991cites this paper
• Chronic fatigue syndrome: I. Epstein‐Barr virus immune response and molecular epidemiology

  1991cites this paper
• Western blot analysis of antibody specificities in subacute sclerosing panencephalitis: reactivity to measles virus proteins produced in persistently infected cells.

  1991cites this paper
• Coinfection with A- and B-type Epstein-Barr virus in human immunodeficiency virus-positive subjects.

  1990cites this paper
• Possible role of Epstein-Barr virus infection in cutaneous T-cell lymphomas.

  1990cites this paper
• Antibody responses against polypeptide components of Epstein‐Barr virus‐induced early diffuse antigen in patients with connective tissue diseases

  1990cites this paper
• Expression of Epstein-Barr virus nuclear antigens 3, 4, and 6 are altered in cell lines containing B-type virus.

  1989cites this paper
• Clinical Syndromes Associated with Epstein-Barr Virus

  1989cites this paper
• Relationship between an antibody to EBV-determined nuclear antigen and an antibody to rheumatoid arthritis nuclear antigen.

  1989cites this paper
• Epstein-Barr virus infection and autoimmunity in rheumatoid arthritis.

  1988cites this paper
• Epstein-Barr virus nuclear antigens 1 and 2 in Burkitt lymphoma cell lines containing either 'A'- or 'B'-type virus.

  1988cites this paper
• Detection of antibodies to the Epstein-Barr virus nuclear antigens in the sera from patients with systemic lupus erythematosus.

  1988cites this paper
• Epstein-Barr virus and human autoimmune diseases: possibilities and pitfalls.

  1988cites this paper
• Cytotoxic T-cell clones discriminate between A- and B-type Epstein-Barr virus transformants

  1988cites this paper
• Prevalence of antibodies to Epstein-Barr virus nuclear antigen 2B in persons infected with the human immunodeficiency virus.

  1988cites this paper
• Reaction of antibodies to rheumatoid arthritis nuclear antigen with a synthetic peptide corresponding to part of Epstein-Barr nuclear antigen 1.

  1988cites this paper
• The 5' flanking region of the gene for the Epstein-Barr virus-encoded nuclear antigen 2 contains a cell type specific cis-acting regulatory element that activates transcription in transfected B-cells.

  1988cites this paper
• Specific epstein-barr virus serological response in patients with nasopiiaryngeal carcinoma detected by immunoblotting

  1988cites this paper
• Three epstein‐barr virus (EBV)‐determined nuclear antigens induced by the BamHI E region of EBV DNA

  1988cites this paper
• Prediction and demonstration of a novel Epstein-Barr virus nuclear antigen.

  1988cites this paper
• The Epstein-Barr virus proteins.

  1988cites this paper
• Purification and characterization of the epstein‐barr virus nuclear antigen 2 using monoclonal antipeptide antibodies

  1988cites this paper
• Is there a role for Epstein-Barr virus in the aetiology of rheumatoid arthritis?

  1988cites this paper
• Herpesviridae: Epstein-Bair Virus

  1988cites this paper
• Malignant Catarrhal Fever in Asian Livestock

  1988cites this paper
• Novel nuclear antigens recognized by human sera in lymphocytes latently infected by Epstein-Barr virus.

  1987cites this paper
• Antibody response against the Epstein‐Barr virus‐coded nuclear antigen2 (EBNA2) in different groups of individuals

  1987cites this paper
• Identification of sequences in Epstein-Barr virus DNA required for the expression of the second Epstein-Barr virus-determined nuclear antigen in COS-1 cells.

  1987cites this paper
• Variation in Epstein-Barr Virus Strains

  1987cites this paper
• Analysis of immune complexes in rheumatoid arthritis for Epstein-Barr virus antigens reveals cross-reactivity of viral capsid antigen and human IgG.

  1987cites this paper
• The infectious etiology of chronic rheumatic diseases.

  1987cites this paper
• Detection of Epstein-Barr virus strain variants in lymphoblastoid cell lines 'spontaneously' derived from patients with rheumatoid arthritis, infectious mononucleosis and normal controls.

  1987cites this paper
• New type B isolates of Epstein-Barr virus from Burkitt's lymphoma and from normal individuals in endemic areas.

  1987cites this paper
• Epstein‐barr virus‐specific t‐cell recognition of B‐cell transformants expressing different ebna 2 antigens

  1987cites this paper
• The prevalence of antibodies to an Epstein-Barr virus-induced polypeptide (EBNA-2) in the sera of rheumatoid arthritic families.

  1987cites this paper
• Correlation between the presence of antibodies to the Epstein-Barr virus nuclear antigen type 2 and antibodies to the rheumatoid arthritis nuclear antigen in patients with rheumatoid arthritis.

  1986cites this paper
• Definitive identification of a member of the Epstein-Barr virus nuclear protein 3 family.

  1986cites this paper
• Induction ofEpstein-Barr VirusNuclear Antigens

  1986cites this paper
• The abnormal cytotoxic T cell response to Epstein-Barr virus in rheumatoid arthritis is correlated with disease activity and occurs in other arthropathies.

  1986cites this paper
• Reactions of sera from patients with rheumatoid arthritis, systemic lupus erythematosus and infectious mononucleosis to Epstein-Barr virus-induced polypeptides.

  1986cites this paper
• Disturbance of the Epstein-Barr virus-host balance in rheumatoid arthritis patients: a quantitative study.

  1986cites this paper
• Four virally determined nuclear antigens are expressed in Epstein-Barr virus-transformed cells.

  1986cites this paper
• Kinetics of the antibody response to BamHI-K nuclear antigen in uncomplicated infectious mononucleosis.

  1986cites this paper
• Lymphoblastoid cell lines and burkitt‐lymphoma‐derivee cell lines differ in the expression of a second epstein‐barr virus encoded nuclear antigen

  1986cites this paper
• Induction of Epstein-Barr virus nuclear antigens

  1986cites this paper
• A family study of the prevalence of antibodies to the rheumatoid arthritis associated nuclear antigen (RANA).

  1986cites this paper
• Geographical prevalence of two types of Epstein-Barr virus.

  1986cites this paper
• Identification of Epstein-Barr virus-induced polypeptides in P3HR-1 cells by protein immunoblot.

  1985cites this paper
• Epstein-Barr virus in rheumatoid arthritis.

  1985cites this paper
• Identification of Multiple Epstein-Barr Virus Nuclear Antigens

  1985cites this paper
• Antibodies against synthetic peptides react with the second Epstein‐Barr virus‐associated nuclear antigen.

  1985cites this paper
• A third viral nuclear protein in lymphoblasts immortalized by Epstein-Barr virus.

  1985cites this paper
• Identification and expression of a nuclear antigen from the genomic region of the Jijoye strain of Epstein-Barr virus that is missing in its nonimmortalizing deletion mutant, P3HR-1.

  1985cites this paper